Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
$606.28
+0.5%
$571.73
$348.63
$674.75
$836.67M0.8463,624 shs58,382 shs
PAR Technology Corporation stock logo
PAR
PAR Technology
$18.72
-1.7%
$16.55
$11.59
$54.62
$774.26M1.331.48 million shs418,720 shs
Riskified Ltd. stock logo
RSKD
Riskified
$6.27
-4.1%
$5.18
$3.70
$6.61
$928.90M1.38874,477 shs1.63 million shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$3.91
-0.8%
$8.30
$3.77
$21.41
$201.10M-0.2260,304 shs194,794 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
0.00%+6.84%+1.72%+26.64%+41.59%
PAR Technology Corporation stock logo
PAR
PAR Technology
0.00%+7.60%+16.74%+36.12%-63.63%
Riskified Ltd. stock logo
RSKD
Riskified
0.00%+23.19%+24.59%+36.86%+24.24%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
0.00%-2.48%-21.98%-58.00%-71.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
$606.28
+0.5%
$571.73
$348.63
$674.75
$836.67M0.8463,624 shs58,382 shs
PAR Technology Corporation stock logo
PAR
PAR Technology
$18.72
-1.7%
$16.55
$11.59
$54.62
$774.26M1.331.48 million shs418,720 shs
Riskified Ltd. stock logo
RSKD
Riskified
$6.27
-4.1%
$5.18
$3.70
$6.61
$928.90M1.38874,477 shs1.63 million shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$3.91
-0.8%
$8.30
$3.77
$21.41
$201.10M-0.2260,304 shs194,794 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
0.00%+6.84%+1.72%+26.64%+41.59%
PAR Technology Corporation stock logo
PAR
PAR Technology
0.00%+7.60%+16.74%+36.12%-63.63%
Riskified Ltd. stock logo
RSKD
Riskified
0.00%+23.19%+24.59%+36.86%+24.24%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
0.00%-2.48%-21.98%-58.00%-71.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
2.00
HoldN/AN/A
PAR Technology Corporation stock logo
PAR
PAR Technology
2.50
Moderate Buy$24.6131.47% Upside
Riskified Ltd. stock logo
RSKD
Riskified
2.13
Hold$6.432.53% Upside
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ZSQR, RSKD, DJCO, and PAR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
Riskified Ltd. stock logo
RSKD
Riskified
Boost Price TargetBuy$6.00 ➝ $7.50
8/13/2026
Riskified Ltd. stock logo
RSKD
Riskified
Boost Price TargetNeutral$5.00 ➝ $6.75
8/13/2026
Riskified Ltd. stock logo
RSKD
Riskified
Boost Price TargetMarket Perform$5.50 ➝ $6.25
8/12/2026
Riskified Ltd. stock logo
RSKD
Riskified
Boost Price TargetSell$4.75 ➝ $5.50
8/7/2026
PAR Technology Corporation stock logo
PAR
PAR Technology
Lower Price TargetBuy$45.00 ➝ $30.00
8/7/2026
PAR Technology Corporation stock logo
PAR
PAR Technology
Boost Price TargetNeutral$17.00 ➝ $18.00
7/23/2026
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
UpgradeHold (C-)Hold (C)
7/13/2026
Riskified Ltd. stock logo
RSKD
Riskified
Boost Price TargetMarket Perform$5.25 ➝ $5.50
7/10/2026
PAR Technology Corporation stock logo
PAR
PAR Technology
Reiterated RatingSell (E+)
7/9/2026
PAR Technology Corporation stock logo
PAR
PAR Technology
Boost Price TargetNeutral$18.00 ➝ $20.50
7/1/2026
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
DowngradeHold (C)Hold (C-)
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
$87.70M9.54$82.04 per share7.39$283.91 per share2.14
PAR Technology Corporation stock logo
PAR
PAR Technology
$455.55M1.70$0.59 per share31.87$20.33 per share0.92
Riskified Ltd. stock logo
RSKD
Riskified
$344.64M2.70N/AN/A$1.99 per share3.15
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/A$2.63 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
$112.14M-$8.22N/AN/AN/A-11.63%-3.11%-2.24%N/A
PAR Technology Corporation stock logo
PAR
PAR Technology
-$84.46M-$1.76N/A25.64N/A-14.52%-1.62%-0.97%11/5/2026 (Estimated)
Riskified Ltd. stock logo
RSKD
Riskified
-$27.57M-$0.11N/A39.19N/A-4.23%-3.93%-2.79%N/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$1.63N/AN/AN/A-773.72%-49.45%-46.88%N/A

Latest ZSQR, RSKD, DJCO, and PAR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/AN/A
8/12/2026Q3 2026
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
N/A-$7.90N/A-$7.90N/A$26.98 million
8/12/2026Q2 2026
Riskified Ltd. stock logo
RSKD
Riskified
$0.0150$0.02+$0.0050-$0.07$89.18 million$98.69 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
N/AN/AN/AN/AN/A
PAR Technology Corporation stock logo
PAR
PAR Technology
N/AN/AN/AN/AN/A
Riskified Ltd. stock logo
RSKD
Riskified
N/AN/AN/AN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
0.06
11.65
11.65
PAR Technology Corporation stock logo
PAR
PAR Technology
0.52
2.21
1.89
Riskified Ltd. stock logo
RSKD
Riskified
N/A
3.62
3.62
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A
7.66
7.66

Institutional Ownership

CompanyInstitutional Ownership
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
51.23%
PAR Technology Corporation stock logo
PAR
PAR Technology
N/A
Riskified Ltd. stock logo
RSKD
Riskified
58.98%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
0.09%
PAR Technology Corporation stock logo
PAR
PAR Technology
2.30%
Riskified Ltd. stock logo
RSKD
Riskified
17.40%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Daily Journal Corp. (S.C.) stock logo
DJCO
Daily Journal Corp. (S.C.)
3201.38 million1.38 millionNot Optionable
PAR Technology Corporation stock logo
PAR
PAR Technology
1,80941.36 million40.41 millionOptionable
Riskified Ltd. stock logo
RSKD
Riskified
780148.15 million122.37 millionOptionable
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
251.43 million38.96 millionNot Optionable

Recent News About These Companies

Z Squared Inc. Provides Capital Structure Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Daily Journal Corp. (S.C.) stock logo

Daily Journal Corp. (S.C.) NASDAQ:DJCO

$606.28 +2.95 (+0.49%)
As of 03:15 PM Eastern

Daily Journal Corporation operates in publishing of newspapers and websites covering in California, Arizona, Utah, and Australia. It operates in two segments, Traditional Business and Journal Technologies. The company publishes 10 newspapers of general circulation, including Los Angeles Daily Journal, San Francisco Daily Journal, Daily Commerce, The Daily Recorder, The Inter-City Express, San Jose Post-Record, Orange County Reporter, Business Journal, The Daily Transcript, and The Record Reporter. It also provides specialized information services; and serves as an advertising and newspaper representative for commercial and public notice advertising. In addition, the company offers case management software systems and related products, including eCourt, eProsecutor, eDefender, and eProbation, which are browser-based case processing systems; eFile, a browser-based interface that allows attorneys and the public to electronically file documents with the court; and ePayIt, a service primarily for the online payment of traffic citations. It provides its software systems and related products to courts; prosecutor and public defender offices; probation departments; and other justice agencies, including administrative law organizations, city and county governments, and bar associations to manage cases and information electronically, to interface with other justice partners, and to extend electronic services to bar members and the public in 30 states and internationally. Daily Journal Corporation was incorporated in 1987 and is based in Los Angeles, California.

PAR Technology stock logo

PAR Technology NYSE:PAR

$18.72 -0.33 (-1.73%)
As of 03:16 PM Eastern

PAR Technology Corporation, together with its subsidiaries, provides omnichannel cloud-based hardware and software solutions to the restaurant and retail industries worldwide. The Restaurant/Retail segment offers PUNCHH, an enterprise-grade customer loyalty and engagement solution; MENU, an eCommerce platform for restaurant brands; BRINK POS, an open cloud, point-of-sale solution; PAR PAYMENT SERVICES, a merchant services business that enables electronic payment and processing services for businesses; and DATA CENTRAL, a back-office solution that leverages business intelligence and automation technologies. This segment also offers Point-of-Sale Hardware; wireless headsets for drive-thru order-taking; and kitchen display systems, payment devices, cash drawers, printers, and other peripherals. In addition, this segment provides services, such as hardware repair, installation and implementation, training, and on-site and technical support services. The Government segment provides intelligence, surveillance, and reconnaissance solutions; mission systems operations and maintenance, and commercial software products; systems engineering support and software-based solutions; satellite and teleport facility operation and maintenance, engineering, and installation services comprising inside and outside plant services, and maintenance of infrastructure and information systems; satellite ground system support comprising operations and maintenance, sustainment, upgrades, communications security management, anomaly response/resolution, process improvement, emergency response, and disaster recovery services; and information technology infrastructure library services to the United States Department of Defense, intelligence community (IC), and other federal agencies. This segment also offers various IC support services, systems integration, situational awareness solutions, and mission readiness support services. The company was founded in 1968 and is based in New Hartford, New York.

Riskified stock logo

Riskified NYSE:RSKD

$6.27 -0.27 (-4.13%)
As of 03:16 PM Eastern

Riskified Ltd., together with its subsidiaries, develops and offers an e-commerce risk management platform that allows online merchants to create trusted relationships with consumers in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and the Americas. It offers Chargeback Guarantee that ensures the legitimacy of merchants' online orders; Policy Protect, a machine learning solution designed to detect and prevent refund and returns policy abuse in real-time; Account Secure, a solution that cross-checks every login attempt; Dispute Resolve, which is used to compile submissions for fraud and non-fraud related chargeback issues; and PSD2 Optimize that helps merchants avoid bank authorization failures and abandoned shopping carts. The company serves direct-to-consumer brands, online-only retailers, omnichannel retailers, online marketplaces, and e-commerce service providers in various industries, such as payments, money transfer and crypto, tickets and travel, electronics, home, and fashion and luxury goods. Riskified Ltd. was incorporated in 2012 and is headquartered in Tel Aviv, Israel.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$3.91 -0.03 (-0.76%)
As of 03:15 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.